Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        61-72 of 115 results

        Refine research

        Research

        Whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children

        Atopic diseases are the most common chronic conditions of childhood. The apparent rise in food anaphylaxis in young children over the past three decades is of particular concern, owing to the lack of proven prevention strategies other than the timely introduction of peanut and egg. ...

        Research

        Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children

        Population-level studies of severe pertussis extending beyond infancy are sparse, and none in the context of antenatal vaccination. We compared hospitalized pertussis cases from birth to 15 years of age before and after introduction of antenatal immunization. ...

        Research

        Whole-Cell Pertussis Vaccination and Decreased Risk of IgE-Mediated Food Allergy: A Nested Case-Control Study

        Australian infants who received whole-cell pertussis vaccines were less likely to be diagnosed with food allergy in childhood ...

        Research

        Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study

        The P3-MumBubVax intervention is feasible and acceptable in the Australian public antenatal setting ...

        Research

        Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data

        No new safety concerns were identified for live attenuated herpes zoster vaccine in this study based on a novel, Australian primary care data source ...

        Research

        Effectiveness of rotavirus vaccines in an Australian population: A case-control study

        RV1 and RV5 were both effective in preventing laboratory confirmed and notified rotavirus infections among children aged <5 years ...

        Research

        The ORVAC trial: A clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

        We hypothesised that scheduling an additional (third) dose of oral human rotavirus vaccine for children aged 6 to <12 months would improve protection ...

        Research

        Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology

        We propose more precision in the term 'vaccine hesitancy' is needed particularly since much under-vaccination arises from factors related to access or pragmatics ...

        Research

        Paediatric antimicrobial stewardship and safe prescribing: An assessment of medical staff knowledge and behaviour

        Participants demonstrated a good understanding of safe prescribing and antimicrobial stewardship ...

        Research

        Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study

        On-time coverage of the 2-4-6 month schedule is only 50-60% across specific population subgroups representing a significant avoidable public health risk ...

        Research

        Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective

        This review supports the recommended use of palivizumab for reducing RSV-associated hospitalisation rates in premature babies born at gestational age <33 weeks. ...

        Research

        Impact of high coverage of monovalent human rotavirus vaccine on Emergency Department presentations for rotavirus gastroenteritis

        The program was associated with a substantial decline in rotavirus attributable non-admitted AGE presentations to ED among children aged <5 years. ...

        Page 6 of 10